Treatment of Necrobiotic Xanthogranuloma With Upadacitinib: A Case Report.

Authors

Austinn C. Miller, HCA HealthcareFollow
Tanner Harding, HCA HealthcareFollow
Jessica Houpe, HCA HealthcareFollow
Emily Jacox, HCA HealthcareFollow
András Schaffer, HCA HealthcareFollow
Amit Jain
Michael Bernhardt, HCA HealthcareFollow

Division

North Florida

Hospital

Capital Regional Medical Center

Document Type

Case Report

Publication Date

5-30-2025

Keywords

JAK inhibitor; Janus kinase inhibitor; Upadacitinib; necrobiotic xanthogranuloma (NXG)

Disciplines

Dermatology | Medicine and Health Sciences

Abstract

No abstract available.

Publisher or Conference

International Journal of Dermatology

Recommended Citation

Miller AC, Harding T, Houpe J, et al. Treatment of Necrobiotic Xanthogranuloma With Upadacitinib: A Case Report. Int J Dermatol. doi:10.1111/ijd.17873